{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:27:40Z","timestamp":1790357260593,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008893","name":"University of Iowa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008893","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omta.2026.201799","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:17:29Z","timestamp":1782775049000},"page":"201799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Engineering hematopoietic stem and progenitor cells to generate red blood cells as viral traps against HIV-1"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9173-9518","authenticated-orcid":false,"given":"Sofia E.","family":"Luna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William N.","family":"Feist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaya","family":"Ben-Efraim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Pendergast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freja K.","family":"Ekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1913-2073","authenticated-orcid":false,"given":"Britney","family":"Hernandez-Naughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Merritt-Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zak","family":"Kostamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson A.","family":"Amorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana Y.","family":"Ghanim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3850-4648","authenticated-orcid":false,"given":"Matthew H.","family":"Porteus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201799_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00232-020-00136-z","article-title":"Entry Inhibitors: Efficient Means to Block Viral Infection","volume":"253","author":"Pattnaik","year":"2020","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.omta.2026.201799_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105834","article-title":"Neutralizing antibodies to block viral entry and for identification of entry inhibitors","volume":"224","author":"Tam","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.omta.2026.201799_bib3","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.it.2021.10.006","article-title":"Hematopoiesis in numbers","volume":"42","author":"Cosgrove","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.omta.2026.201799_bib4","doi-asserted-by":"crossref","first-page":"12897","DOI":"10.1073\/pnas.0506211102","article-title":"The erythrocyte viral trap: Transgenic expression of viral receptor on erythrocytes attenuates coxsackievirus B infection","volume":"102","author":"Asher","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201799_bib5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrd3499","article-title":"Bio-inspired, bioengineered and biomimetic drug delivery carriers","volume":"10","author":"Yoo","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omta.2026.201799_bib6","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood-2008-09-178459","article-title":"Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1","volume":"113","author":"Carlisle","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201799_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jconrel.2004.08.005","article-title":"Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes","volume":"100","author":"Chambers","year":"2004","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.omta.2026.201799_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/iub.478","article-title":"Drug delivery by red blood cells","volume":"63","author":"Biagiotti","year":"2011","journal-title":"IUBMB Life"},{"key":"10.1016\/j.omta.2026.201799_bib9","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1182\/blood-2010-01-261610","article-title":"Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation","volume":"115","author":"Zaitsev","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201799_bib10","doi-asserted-by":"crossref","first-page":"10131","DOI":"10.1073\/pnas.1409861111","article-title":"Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes","volume":"111","author":"Shi","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.omta.2026.201799_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.omtm.2021.03.003","article-title":"In vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2","volume":"21","author":"Hoffmann","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201799_bib12","first-page":"222","article-title":"Red blood cell storage time and transfusion: current practice, concerns and future perspectives","volume":"15","author":"Garc\u00eda-Roa","year":"2017","journal-title":"Blood Transfus"},{"key":"10.1016\/j.omta.2026.201799_bib13","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006866","article-title":"HIV: Cell Binding and Entry","volume":"2","author":"Wilen","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.omta.2026.201799_bib14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/COH.0000000000000367","article-title":"Engineering antibody-like inhibitors to prevent and treat HIV-1 infection","volume":"12","author":"Gardner","year":"2017","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.omta.2026.201799_bib15","doi-asserted-by":"crossref","first-page":"18719","DOI":"10.1073\/pnas.2010320117","article-title":"Nanoparticles presenting clusters of CD4 expose a universal vulnerability of HIV-1 by mimicking target cells","volume":"117","author":"Hoffmann","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201799_bib16","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1073\/pnas.87.17.6574","article-title":"High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates","volume":"87","author":"Daar","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201799_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/339068a0","article-title":"Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules","volume":"339","author":"Traunecker","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201799_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature14264","article-title":"AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges","volume":"519","author":"Gardner","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201799_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5409","article-title":"AAV-delivered eCD4-Ig protects rhesus macaques from high-dose SIVmac239 challenges","volume":"11","author":"Gardner","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omta.2026.201799_bib20","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41551-024-01222-6","article-title":"Enhancement of erythropoietic output by Cas9-mediated insertion of a natural variant in haematopoietic stem and progenitor cells","volume":"8","author":"Luna","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omta.2026.201799_bib21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/337368a0","article-title":"Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells","volume":"337","author":"Clapham","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201799_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.omta.2026.201799_bib24","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omta.2026.201799_bib25","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1016\/j.ymthe.2023.09.004","article-title":"Myelodysplasia after clonal hematopoiesis with APOBEC3-mediated CYBB inactivation in retroviral gene therapy for X-CGD","volume":"31","author":"Uchiyama","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201799_bib26","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa2405541","article-title":"Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy","volume":"391","author":"Duncan","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201799_bib27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/s41591-021-01284-y","article-title":"Gene replacement of \u03b1-globin with \u03b2-globin restores hemoglobin balance in \u03b2-thalassemia-derived hematopoietic stem and progenitor cells","volume":"27","author":"Cromer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201799_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb0411","article-title":"Sustained fetal hemoglobin induction in vivo is achieved by BCL11A interference and coexpressed truncated erythropoietin receptor","volume":"13","author":"Uchida","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omta.2026.201799_bib29","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41467-019-09614-y","article-title":"Gene correction for SCID-X1 in long-term hematopoietic stem cells","volume":"10","author":"Pavel-Dinu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201799_bib30","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41587-023-01888-4","article-title":"High-efficiency transgene integration by homology-directed repair in human primary cells using DNA-PKcs inhibition","volume":"42","author":"Selvaraj","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201799_bib31","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ymthe.2019.05.014","article-title":"Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates","volume":"27","author":"Romero","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201799_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41467-023-43413-w","article-title":"Transient inhibition of 53BP1 increases the frequency of targeted integration in human hematopoietic stem and progenitor cells","volume":"15","author":"Baik","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201799_bib33","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.stem.2022.09.001","article-title":"Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells","volume":"29","author":"Ferrari","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omta.2026.201799_bib34","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1182\/blood-2015-09-667923","article-title":"Pomalidomide reverses \u03b3-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors","volume":"127","author":"Dulmovits","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201799_bib35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.stem.2024.03.002","article-title":"A simultaneous knockout knockin genome editing strategy in HSPCs potently inhibits CCR5- and CXCR4-tropic HIV-1 infection","volume":"31","author":"Dudek","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omta.2026.201799_bib36","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1128\/JVI.02853-13","article-title":"Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies","volume":"88","author":"deCamp","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201799_bib37","series-title":"Blood Groups and Red Cell Antigens","article-title":"Blood and the cells it contains","author":"Dean","year":"2005"},{"key":"10.1016\/j.omta.2026.201799_bib38","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-Term Control of HIV by CCR5 Delta32\/Delta32 Stem-Cell Transplantation","volume":"360","author":"H\u00fctter","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201799_bib39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5\u039432\/\u039432 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201799_bib40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-023-02213-x","article-title":"In-depth virological and immunological characterization of HIV-1 cure after CCR5\u039432\/\u039432 allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Jensen","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201799_bib41","series-title":"CROI Conference","article-title":"531 - Sustained HIV Remission Despite Transient Rebound Viremia After a CCR5\u039432\/\u039432 Stem Cell Transplant","year":"2026"},{"key":"10.1016\/j.omta.2026.201799_bib42","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-025-09893-0","article-title":"Sustained HIV-1 remission after heterozygous CCR5\u039432 stem cell transplantation","volume":"650","author":"Gaebler","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201799_bib43","series-title":"CROI Conference","article-title":"532 - HIV Remission After Allogeneic Hematopoietic Stem Cell Transplant From CCR5\u039432\/\u039432 Sibling Donor","year":"2026"},{"key":"10.1016\/j.omta.2026.201799_bib44","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.cell.2023.02.030","article-title":"HIV-1 remission and possible cure in a woman after haplo-cord blood transplant","volume":"186","author":"Hsu","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201799_bib45","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMc2312556","article-title":"HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation","volume":"390","author":"Dickter","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201799_bib46","doi-asserted-by":"crossref","first-page":"F67","DOI":"10.1097\/00002030-199710000-00001","article-title":"Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient","volume":"11","author":"Balotta","year":"1997","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.omta.2026.201799_bib47","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1056\/NEJMc1405805","article-title":"Shift of HIV Tropism in Stem-Cell Transplantation with CCR5 Delta32 Mutation","volume":"371","author":"Kordelas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201799_bib48","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.omtm.2023.07.009","article-title":"Molecular dynamics of genome editing with CRISPR-Cas9 and rAAV6 virus in human HSPCs to treat sickle cell disease","volume":"30","author":"Xu","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201799_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66318-2","article-title":"Circular single stranded DNA potentiates non-viral gene insertion in hematopoietic stem and progenitor cells","volume":"16","author":"Letort","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201799_bib50","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood.2022019333","article-title":"Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells","volume":"142","author":"Vavassori","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201799_bib51","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1182\/blood-2010-11-321414","article-title":"Macrophages prevent human red blood cell reconstitution in immunodeficient mice","volume":"118","author":"Hu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201799_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642198","article-title":"Development of LT-HSC-Reconstituted Non-Irradiated NBSGW Mice for the Study of Human Hematopoiesis In Vivo","volume":"12","author":"Adigbli","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201799_bib53","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41467-025-55873-3","article-title":"High frequency CCR5 editing in human hematopoietic stem progenitor cells protects xenograft mice from HIV infection","volume":"16","author":"Claiborne","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201799_bib54","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ymthe.2017.04.027","article-title":"CRISPR\/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem\/Progenitor Cells Confers HIV-1 Resistance In Vivo","volume":"25","author":"Xu","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201799_bib55","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1038\/s41467-025-58371-8","article-title":"Multilayered HIV-1 resistance in HSPCs through CCR5 Knockout and B cell secretion of HIV-inhibiting antibodies","volume":"16","author":"Feist","year":"2025","journal-title":"Nat Commun."},{"key":"10.1016\/j.omta.2026.201799_bib56","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1128\/JVI.03608-14","article-title":"HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies","volume":"89","author":"Lynch","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201799_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00443-19","article-title":"eCD4-Ig Limits HIV-1 Escape More Effectively than CD4-Ig or a Broadly Neutralizing Antibody","volume":"93","author":"Fellinger","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201799_bib58","doi-asserted-by":"crossref","first-page":"E1604","DOI":"10.1073\/pnas.1503532112","article-title":"The coreceptor CD4 is expressed in distinct nanoclusters and does not colocalize with T-cell receptor and active protein tyrosine kinase p56lck","volume":"112","author":"Roh","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.omta.2026.201799_bib59","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1128\/JVI.75.8.3779-3790.2001","article-title":"CCR5, CXCR4, and CD4 Are Clustered and Closely Apposed on Microvilli of Human Macrophages and T Cells","volume":"75","author":"Singer","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201799_bib60","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1371\/journal.ppat.0030063","article-title":"Electron Tomography of the Contact between T Cells and SIV\/HIV-1: Implications for Viral Entry","volume":"3","author":"Sougrat","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omta.2026.201799_bib61","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.1226359","article-title":"Maturation-Dependent HIV-1 Surface Protein Redistribution Revealed by Fluorescence Nanoscopy","volume":"338","author":"Chojnacki","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.omta.2026.201799_bib62","doi-asserted-by":"crossref","first-page":"11456","DOI":"10.1074\/jbc.M111191200","article-title":"Biochemical and Biological Characterization of a Dodecameric CD4-Ig Fusion Protein: IMPLICATIONS FOR THERAPEUTIC AND VACCINE STRATEGIES","volume":"277","author":"Arthos","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201799_bib63","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/aid.1993.9.595","article-title":"Soluble CD4 and CD4 immunoglobulin-selected HIV-1 variants: a phenotypic characterization","volume":"9","author":"Klasse","year":"1993","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.omta.2026.201799_bib64","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.stem.2014.10.004","article-title":"Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR\/Cas9","volume":"15","author":"Mandal","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omta.2026.201799_bib65","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.27873","article-title":"Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR\/Cas9 and AAV6","volume":"6","author":"Bak","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.omta.2026.201799_bib66","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.ymthe.2023.07.016","article-title":"Dual-locus, dual-HDR editing permits efficient generation of antigen-specific regulatory T cells with robust suppressive activity","volume":"31","author":"Hunt","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201799_bib67","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/hgtb.2011.034","article-title":"Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences","volume":"23","author":"Aurnhammer","year":"2012","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omta.2026.201799_bib68","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nprot.2017.143","article-title":"CRISPR\/Cas9 genome editing in human hematopoietic stem cells","volume":"13","author":"Bak","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omta.2026.201799_bib69","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201799_bib70","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1038\/s41467-019-11962-8","article-title":"Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I","volume":"10","author":"Gomez-Ospina","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201799_bib71","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1182\/blood-2013-01-476390","article-title":"Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201799_bib72","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"79","author":"Li","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201799_bib73","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:12:20Z","timestamp":1789053140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26001345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3117387X26001345"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201799","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering hematopoietic stem and progenitor cells to generate red blood cells as viral traps against HIV-1","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201799"}}